Benoit C, Zavecz J, Wang Y
Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, PO Box 33932, 1501 Kings Highway, Shreveport, LA 71130, USA.
Placenta. 2007 May-Jun;28(5-6):498-504. doi: 10.1016/j.placenta.2006.09.002. Epub 2006 Oct 27.
Inadequate blood flow and increased vasoconstriction of the placenta contribute to pregnancy associated disorders such as preeclampsia (PE). Because placental vessels lack autonomic innervation, humoral effects of the placenta must play critical roles in regulation of fetal-placental vascular contractility. In this study, we examined the nature of humoral factors produced by PE trophoblasts on placental vessel contractility using an organ bath perfusion model. Vasomotor responses were studied in vitro using placental chorionic plate arteries. Vessel rings from third branch chorionic plate arteries were dissected from human placentas following normal or PE delivery. The arterial rings were equilibrated in Krebs Henseleit buffer and exposed to placental conditioned medium, which was prepared by culture of villous tissue from PE placentas. Receptor antagonists for angiotensin II (ANG II), thromboxane (TX), and endothelin (ET) were used to determine which humoral factor produced by placental tissue (trophoblasts) was more effective in promoting vasoconstriction. The role of angiotensin converting enzyme (ACE) and non-ACE ANG II generating enzymes in regulation of placental vasomotor tone were also investigated. A total of 80 arterial rings from 48 placentas were studied. Our results showed: 1) enhanced vasomotor tone in arteries from PE placentas compared to those from normal placentas; 2) PE-CM induced vaso-constrictive activity could be partially attenuated by receptor antagonists for TX, ANG II and ET, respectively; and 3) chymostatin (a chymase inhibitor) produced a stronger inhibitory effect than captopril (ACE inhibitor) on PE conditioned medium induced vasoconstriction. Our data demonstrate increased vasocontractility in PE placentas and suggest that the non-ACE pathway is probably a major source of ANG II produced in the human placenta.
胎盘血流不足和血管收缩增强会导致如先兆子痫(PE)等妊娠相关疾病。由于胎盘血管缺乏自主神经支配,胎盘的体液效应必定在调节胎儿-胎盘血管收缩性中起关键作用。在本研究中,我们使用器官浴灌注模型研究了PE滋养层细胞产生的体液因子对胎盘血管收缩性的影响。使用胎盘绒毛膜板动脉在体外研究血管舒缩反应。从正常分娩或PE分娩后的人胎盘中分离出第三分支绒毛膜板动脉的血管环。将动脉环在Krebs Henseleit缓冲液中平衡,并暴露于胎盘条件培养基中,该培养基由PE胎盘的绒毛组织培养制备。使用血管紧张素II(ANG II)、血栓素(TX)和内皮素(ET)的受体拮抗剂来确定胎盘组织(滋养层细胞)产生的哪种体液因子在促进血管收缩方面更有效。还研究了血管紧张素转换酶(ACE)和非ACE ANG II生成酶在调节胎盘血管舒缩张力中的作用。共研究了来自48个胎盘的80个动脉环。我们的结果表明:1)与正常胎盘的动脉相比,PE胎盘的动脉血管舒缩张力增强;2)PE-CM诱导的血管收缩活性可分别被TX、ANG II和ET的受体拮抗剂部分减弱;3)抑肽酶(一种糜酶抑制剂)对PE条件培养基诱导的血管收缩产生的抑制作用比卡托普利(ACE抑制剂)更强。我们的数据表明PE胎盘的血管收缩性增加,并提示非ACE途径可能是人类胎盘中ANG II产生的主要来源。